Smith MR - Search Results

1

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.

Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: smith mr. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.

2

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.

Smith MR, Eastham J, Gleason DM, Shasha D, Tchekmedyian S, Zinner N. Smith MR, et al. J Urol. 2003 Jun;169(6):2008-12. doi: 10.1097/01.ju.0000063820.94994.95. J Urol. 2003. PMID: 12771706 Clinical Trial.

3

Prostate cancer (metastatic).

Michaelson MD, Smith MR, Talcott JA. Michaelson MD, et al. Among authors: smith mr. Clin Evid. 2003 Dec;(10):1012-22. Clin Evid. 2003. PMID: 15555135 Review. No abstract available.

4

Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

Smith MR, Kabbinavar F, Saad F, Hussain A, Gittelman MC, Bilhartz DL, Wynne C, Murray R, Zinner NR, Schulman C, Linnartz R, Zheng M, Goessl C, Hei YJ, Small EJ, Cook R, Higano CS. Smith MR, et al. J Clin Oncol. 2005 May 1;23(13):2918-25. doi: 10.1200/JCO.2005.01.529. J Clin Oncol. 2005. PMID: 15860850 Clinical Trial.

5

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, Smith MR. Efstathiou JA, et al. Among authors: smith mr. Cancer. 2007 Dec 15;110(12):2691-9. doi: 10.1002/cncr.23093. Cancer. 2007. PMID: 17999404 Free PMC article. Clinical Trial.

6

Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C; Denosumab HALT Prostate Cancer Study Group. Smith MR, et al. N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003. Epub 2009 Aug 11. N Engl J Med. 2009. PMID: 19671656 Free PMC article. Clinical Trial.

7

Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.

Smith MR, Saad F, Egerdie B, Szwedowski M, Tammela TL, Ke C, Leder BZ, Goessl C. Smith MR, et al. J Urol. 2009 Dec;182(6):2670-5. doi: 10.1016/j.juro.2009.08.048. J Urol. 2009. PMID: 19836774 Free PMC article. Clinical Trial.

8

A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Kim HS, Moreira DM, Smith MR, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. Kim HS, et al. Among authors: smith mr. BJU Int. 2011 Mar;107(6):924-8. doi: 10.1111/j.1464-410X.2010.09679.x. Epub 2010 Sep 22. BJU Int. 2011. PMID: 20860651 Free PMC article.

9

Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer.

Smith MR, Cook R, Lee KA, Nelson JB. Smith MR, et al. Cancer. 2011 May 15;117(10):2077-85. doi: 10.1002/cncr.25762. Epub 2010 Nov 16. Cancer. 2011. PMID: 21523719 Free PMC article.

10

Effective treatment for early-stage prostate cancer--possible, necessary, or both?

Smith MR. Smith MR. N Engl J Med. 2011 May 5;364(18):1770-2. doi: 10.1056/NEJMe1100787. N Engl J Med. 2011. PMID: 21542749 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,144 results

Search Page